Market Cap

Pharming Group N.V. Market Capitalization:

€1.02 Billion

EUR as of Jan. 1, 2026

US$1.20 Billion

business Pharming Group N.V. Company Profile

Pharming Group N.V. Main Stock Listing

Euronext: PHARM

Market Capitalization History of Pharming Group N.V.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Pharming Group N.V. market cap

Date Market Cap YoY Change
Jan. 1, 2026 €1.02 B 71.33%
Jan. 1, 2025 €594.9 M -16.74%
Jan. 1, 2024 €714.5 M -10.37%
Jan. 1, 2023 €797.2 M 59.90%
Jan. 1, 2022 €498.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Pharming Group N.V. Categories

Netherlands languages Healthcare languages Biotechnology
Netherlands Healthcare Netherlands Biotechnology

Stocks & Indices

Pharming Group N.V. has the following listings and related stock indices.


Stock: Euronext: PHARM

Stock: NASDAQ: PHAR

Stock: FSX: PHGN

Stock: FSX: PHG

Stock: OTC: PHGUF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.